相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Probing Protein-protein Interactions and Druggable Site Identification: Mechanistic Binding Events Between Ubiquitin and Zinc Finger with UFM1-specific Peptidase Domain Protein (ZUFSP)
Mary B. Ajadi et al.
COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING (2022)
PP2A and cancer epigenetics: a therapeutic opportunity waiting to happen
Samantha L. Tinsley et al.
NAR CANCER (2022)
Beyond K48 and K63: non-canonical protein ubiquitination
Michal Tracz et al.
CELLULAR & MOLECULAR BIOLOGY LETTERS (2021)
DNA Polymerase ι Interacts with Both the TRAF-like and UBL1-2 Domains of USP7
Nicholas W. Ashton et al.
JOURNAL OF MOLECULAR BIOLOGY (2021)
Emerging functions of branched ubiquitin chains
Michael E. French et al.
CELL DISCOVERY (2021)
Targeting Ubiquitin-Specific Protease 7 (USP7) in Cancer: A New Insight to Overcome Drug Resistance
Jiabin Lu et al.
FRONTIERS IN PHARMACOLOGY (2021)
Targeting protein phosphatase PP2A for cancer therapy: development of allosteric pharmaceutical agents
David L. Brautigan et al.
CLINICAL SCIENCE (2021)
Regulation of Cancer Metabolism by Deubiquitinating Enzymes: The Warburg Effect
So-Hee Kim et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Review of PP2A Tumor Biology and Antitumor Effects of PP2A Inhibitor LB100 in the Nervous System
Jean-Paul Bryant et al.
CANCERS (2021)
Protein Phosphorylation in Cancer: Role of Nitric Oxide Signaling Pathway
Xinran Liu et al.
BIOMOLECULES (2021)
The emerging nature of Ubiquitin- specific protease 7 (USP7): a new target in cancer therapy
Lauraine Nininahazwe et al.
DRUG DISCOVERY TODAY (2021)
Targeting ubiquitin signaling for cancer immunotherapy
Xiaofei Zhou et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
A systematic approach to quantitative Western blot analysis
Lakshmi Pillai-Kastoori et al.
ANALYTICAL BIOCHEMISTRY (2020)
A new regulatory mechanism of protein phosphatase 2A activity via SET in acute myeloid leukemia
Elena Arriazu et al.
BLOOD CANCER JOURNAL (2020)
Role of Deubiquitinases in Human Cancers: Potential Targeted Therapy
Keng Po Lai et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Protein Stability of Pyruvate Kinase Isozyme M2 Is Mediated by HAUSP
Hae-Seul Choi et al.
CANCERS (2020)
USP7 Is a Master Regulator of Genome Stability
Gabrielle J. Valles et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Multi-Step Ubiquitin Decoding Mechanism for Proteasomal Degradation
Hikaru Tsuchiya et al.
PHARMACEUTICALS (2020)
PP2A-B55 Holoenzyme Regulation and Cancer
Perrine Goguet-Rubio et al.
BIOMOLECULES (2020)
The role of ubiquitination in tumorigenesis and targeted drug discovery
Lu Deng et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Monotherapy efficacy of blood-brain barrier permeable small molecule reactivators of protein phosphatase 2A in glioblastoma
Joni Merisaari et al.
BRAIN COMMUNICATIONS (2020)
Targeting-PP2A-in-cancer: Combination therapies
Sahar Mazhar et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2019)
Emerging drug development technologies targeting ubiquitination for cancer therapeutics
Gianluca Veggiani et al.
PHARMACOLOGY & THERAPEUTICS (2019)
USP7: Structure, substrate specificity, and inhibition
Alexandra Pozhidaeva et al.
DNA REPAIR (2019)
Post-translational regulation of ubiquitin signaling
Lei Song et al.
JOURNAL OF CELL BIOLOGY (2019)
USP7: Novel Drug Target in Cancer Therapy
Zhiru Wang et al.
FRONTIERS IN PHARMACOLOGY (2019)
TGF- signaling pathway mediated by deubiquitinating enzymes
Soo-Yeon Kim et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2019)
Deubiquitinating enzymes as cancer biomarkers: new therapeutic opportunities?
Naresh Poondla et al.
BMB REPORTS (2019)
Therapeutic targeting of PP2A
Caitlin M. O'Connor et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2018)
Use of the REVERT® total protein stain as a loading control demonstrates significant benefits over the use of housekeeping proteins when analyzing brain homogenates by Western blot: An analysis of samples representing different gonadal hormone states
Z. Z. Kirshner et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2018)
Identification and Characterization of USP7 Targets in Cancer Cells
Anna Georges et al.
SCIENTIFIC REPORTS (2018)
Deubiquitinating Enzymes Related to Autophagy: New Therapeutic Opportunities?
Anne-Claire Jacomin et al.
CELLS (2018)
Regulation of USP7: A High Incidence of E3 Complexes
Robbert Q. Kim et al.
JOURNAL OF MOLECULAR BIOLOGY (2017)
All roads lead to PP2A: exploiting the therapeutic potential of this phosphatase
Jaya Sangodkar et al.
FEBS JOURNAL (2016)
Recurrent PPP2R1A Mutations in Uterine Cancer Act through a Dominant-Negative Mechanism to Promote Malignant Cell Growth
Dorien Haesen et al.
CANCER RESEARCH (2016)
PP2A as a master regulator of the cell cycle
Nathan Wlodarchak et al.
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY (2016)
The emerging role of deubiquitinating enzymes in genomic integrity, diseases, and therapeutics
Mingjing He et al.
CELL AND BIOSCIENCE (2016)
The broken Off switch in cancer signaling: PP2A as a regulator of tumorigenesis, drug resistance, and immune surveillance
Peter P. Ruvolo
BBA CLINICAL (2016)
Targeting signaling factors for degradation, an emerging mechanism for TRAF functions
Xiao-Dong Yang et al.
IMMUNOLOGICAL REVIEWS (2015)
Annexin-1 regulated by HAUSP is essential for UV-induced damage response
J-J Park et al.
CELL DEATH & DISEASE (2015)
HAUSP regulates c-MYC expression via de-ubiquitination of TRRAP
Seemana Bhattacharya et al.
CELLULAR ONCOLOGY (2015)
PP2A Inhibition Is a Common Event in Colorectal Cancer and Its Restoration Using FTY720 Shows Promising Therapeutic Potential
Ion Cristobal et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Impaired expression of protein phosphatase 2A subunits enhances metastatic potential of human prostate cancer cells through activation of AKT pathway
P. Pandey et al.
BRITISH JOURNAL OF CANCER (2013)
Phosphatase: PP2A structural importance, regulation and its aberrant expression in cancer
Parthasarathy Seshacharyulu et al.
CANCER LETTERS (2013)
Protein phosphatase 2A: a target for anticancer therapy
Danilo Perrotti et al.
LANCET ONCOLOGY (2013)
Novel Molecular Targets in Malignant Diseases of Digestive System
Chunping Jiang et al.
GASTROENTEROLOGY RESEARCH AND PRACTICE (2013)
Molecular recognition of p53 and MDM2 by USP7/HAUSP
Y Sheng et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2006)
Heterogeneous nuclear ribonucleoprotein A2 is a SET-binding protein and a PP2A inhibitor
J Vera et al.
ONCOGENE (2006)
HAUSP, a deubiquitinating enzyme for p53, is polyubiquitinated, polyneddylated, and dimerized
HJ Lee et al.
FEBS LETTERS (2005)
分享论文
